The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA
Hashem B El-Serag12, Rebecca Sardell3, Aaron P Thrift45, Fasiha Kanwal6, Paige Miller3
Author information
1Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, 7200 Cambridge St., Houston, TX, 77030, USA. hasheme@bcm.edu.
2Medical Care Line at Michael E. DeBakey VA Medical Center, Houston, TX, USA. hasheme@bcm.edu.
3Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, TX, USA.
4Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
5Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
6Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, 7200 Cambridge St., Houston, TX, 77030, USA.
Abstract
Background: Texas is the second largest state by area and population in the USA and is reported to have high incidence and mortality rates for hepatocellular carcinoma (HCC). The reasons for the increasingly high burden of HCC in Texas are not clear.
Aims: We explored trends and demographic and regional variations in HCC incidence to better understand reasons for the high burden in Texas.
Methods: We analyzed Texas Cancer Registry incidence data from 2001 to 2015 and compared results to the U.S. National Program of Cancer Registries and SEER for the same period. Rates were stratified by sex, race/ethnicity, and age at diagnosis. Rates were also compared between the US/Mexico border region of Texas and the rest of Texas.
Results: Texas had the highest HCC age-adjusted incidence rate of all states, 13.2/100,000, which was 45% higher than the national average. In Texas and nationally, rates increased by 4% per year between 2001 and 2015. Rates in Texas were 26-37% greater than national rates for Hispanics, African-Americans, and non-Hispanic whites. Among Hispanics in states with the largest percentage of Hispanics, Texas-based Hispanics had the highest HCC incidence rate in 2015 (21.2/100,000) compared with Hispanics in New Mexico, California, Arizona, Nevada, and Florida. Incidence rates were highest in South Texas and US/Mexico border regions.
Conclusions: Increasing rates in the large Hispanic population may explain why Texas now has the highest HCC incidence rate in the USA.